120 results

• Invokana Diabetic Ketoacidosis (DKA) Side Effects Are Detectable, Preventable: Researchers

  September 9, 2015

  Austin Kirk

  Researchers say doctors can predict and prevent incidents of Invokana diabetic ketoacidosis through careful monitoring.

• Jardiance Combo Drug Approved by FDA, As Investigation into Ketoacidosis Risk Continues

  September 8, 2015

  Irvin Jackson

  The FDA has approved a new combination drug of Jardiance and metformin, despite concerns about the link between Jardiance and similiar diabetes drugs and cases of ketoacidosis.

• Study Claims Jardiance Lowers Heart Attack, Stroke Risk, But Ketoacidosis Concerns Remain

  August 26, 2015

  Irvin Jackson

  The makers of Jardiance are claiming their drug prevents heart attacks and strokes in diabetics as regulators investigate whether it and similar drugs can cause injuries by elevating blood acid levels.

• Invokana, Farxiga Problems Renew Concerns About Direct-to-Consumer Advertisements

  August 14, 2015

  Austin Kirk

  Amid recent safety questions, concerns have emerged about direct-to-consumer advertisements for Invokana and similar drugs that include off-label marketing weight loss claims.

• Invokana Diabetic Ketoacidosis Problems Rare, Drug Maker’s Researchers Say

  July 28, 2015

  Irvin Jackson

  Janssen researchers claim incidents of Invokana ketoacidosis are rare, despite FDA concerns.

• Invokana Ketoacidosis Side Effects to be Subject of AACE Conference This Fall

  July 8, 2015

  Irvin Jackson

  A conference scheduled for this fall will look at the risks of diabetic ketoacidosis recently linked to Invokana and similar diabetes drugs.

• Diabetic Ketoacidosis on Invokana May Result in Days of Hospitalization

  July 6, 2015

  Austin Kirk

  Invokana- related diabetic ketoacidosis can require days of treatment in a hospital to bring the body's chemistry back into balance.

• Side Effects of Invokana, Farxiga Reviewed by Health Canada

  June 23, 2015

  Irvin Jackson

  Health Canada has launched an investigation into potential ketoacidosis risks of Invokana and similar drugs on the heels of similar FDA and EMA investigations.

• Invokana Studies Presented by J&J Day After Ketoacidosis Warning Issued by FDA

  June 10, 2015

  Irvin Jackson

  Three new manufacturer-sponsored studies published immediately after the FDA issued an Invokana ketoacidosis warning claim the drug provides significant benefits.

• Invokana Problems Lead to Review by European Medicines Agency (EMA)

  May 29, 2015

  Austin Kirk

  Following recent warnings by the FDA, European drug regulators are investigating the potential side effects of Invokana and other similar...